Feb 12, 2020
The Columbus Marathon and Nationwide announced today that they have renewed their partnership for the annual running and walking event through 2024. The two organizations also announced that Nationwide Children’s Hospital will remain the title beneficiary of the event for the next five years.
Feb 11, 2020
Any child from birth to age five can enroll to receive books from the Ohio Governor’s Imagination Library. After enrollment, children will begin receiving a new book each month, at no cost to their family.
Feb 05, 2020
Jan 21, 2020
The Abigail Wexner Research Institute at Nationwide Children’s Hospital Joins Four Other Top Research Institutions in Joint Initiative Focused on Single Ventricle Heart Defects
The Abigail Wexner Research Institute at Nationwide Children’s Hospital announced today that it is the recipient of a $1 million Innovation Fund, endowed by the nonprofit foundation: Additional Ventures. In receiving this funding, AWRI will join four other research institutions in a large-scale coordinated research effort centered on identifying new avenues to functionally cure patients with single ventricle heart defects (SVDs).
Jan 20, 2020
As part of the division of Gastroenterology, Hepatology & Nutrition, the Pancreas Center at Nationwide Children’s provides comprehensive multidisciplinary care for infants, children and teens suffering from diseases of the pancreas.
Jan 13, 2020
Central Ohio’s first commercial-scale gene therapy Good Manufacturing Practices (cGMP) clinical manufacturing facility slated for 2023.
Jan 06, 2020
(COLUMBUS, Ohio) – Following a national search, Lee Ann Wallace, RN, MBA, NEA-BC, current vice president of Neonatal Services at Nationwide Children’s Hospital, has been selected senior vice president and Chief Nursing Officer (CNO) effective March 20.
Dec 17, 2019
Mercy Health – Children’s Hospital and Nationwide Children’s Hospital are pleased to announce an innovative affiliation to enhance pediatric health care services for children and their families in northwest Ohio and southeast Michigan.
Dec 12, 2019
(COLUMBUS, Ohio) – A Phase III clinical trial shows that elexacaftor added to ivacaftor and tezacaftor improves lung function and quality of life in cystic fibrosis patients with the most common genetic mutation, F508del.
Dec 09, 2019
Study Shows Three-Day Intensive Crisis Intervention is Associated with Reduced Suicidality in Adolescents
When an adolescent is acutely suicidal and cannot safely remain in the community, inpatient psychiatric hospitalization is the traditional intervention. But a lack of appropriate facilities across the United States, combined with an increasing demand for inpatient psychiatric services, means many young people who are at critical risk often cannot get the help they need.